Evidence map›Paper›PMID 33779115›Full record

ArticleJournal of biomedical materials research. Part A2021

Suppression of NF-κB-induced chronic inflammation mitigates inflammatory osteolysis in the murine continuous polyethylene particle infusion model.

Takeshi Utsunomiya, Ning Zhang, Tzuhua Lin, Yusuke Kohno, Masaya Ueno, Masahiro Maruyama, Ejun Huang, Claire Rhee, Zhenyu Yao, Stuart B Goodman

Open access · greenAbstract read
In one paragraph

Article in Journal of biomedical materials research. Part A, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Therapeutic effects of MSCs, genetically modified MSCs, and NFĸB-inhibitor on chronic inflammatory osteolysis in aged mice.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2023
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Takeshi UtsunomiyaDepartment of Orthopaedic Surgery, Stanford University, Stanford, California, USA.
Ning ZhangDepartment of Orthopaedic Surgery, Stanford University, Stanford, California, USA.
Tzuhua LinDepartment of Orthopaedic Surgery, Stanford University, Stanford, California, USA.
Yusuke KohnoDepartment of Orthopaedic Surgery, Stanford University, Stanford, California, USA.ORCID 0000-0003-1821-4560
Masaya UenoDepartment of Orthopaedic Surgery, Stanford University, Stanford, California, USA.ORCID 0000-0002-4121-9127
Masahiro MaruyamaDepartment of Orthopaedic Surgery, Stanford University, Stanford, California, USA.
Ejun HuangDepartment of Orthopaedic Surgery, Stanford University, Stanford, California, USA.
Claire RheeDepartment of Orthopaedic Surgery, Stanford University, Stanford, California, USA.
Zhenyu YaoDepartment of Orthopaedic Surgery, Stanford University, Stanford, California, USA.
Stuart B GoodmanDepartment of Orthopaedic Surgery, Stanford University, Stanford, California, USA.
Stanford University · US

Funding

Wear Particle Disease and NF-kappa B SignalingR01AR063717 · NIAMS · STANFORD UNIVERSITY · PI GOODMAN, STUART B · 2012 to 2021
$3.5M
Tissue Engineering Approaches for Improved Treatment of Early Stage Osteonecrosis of the HipR01AR072613 · NIAMS · STANFORD UNIVERSITY · PI GOODMAN, STUART B, YANG, YUNZHI · 2018 to 2022
$2.2M
Customized MSCs to Enhance Healing of Bone DefectsR01AR073145 · NIAMS · STANFORD UNIVERSITY · PI GOODMAN, STUART B · 2018 to 2021
$1.4M
NIAMS NIH HHS R01 AR063717NIAMS NIH HHS R01 AR072613NIAMS NIH HHS R01 AR073145NIH HHS R01AR063717NIH HHS R01AR073145
6 · The paper itself

Abstract

Wear particle-associated bone loss (periprosthetic osteolysis) constrains the longevity of total joint arthroplasty (TJA). Wear particles induce a prolonged upregulation of nuclear factor kappa B (NF-κB) signaling in macrophages and osteoclasts. Synthetic double-stranded oligodeoxynucleotides (ODNs) can prevent the binding of NF-κB to the promoter regions of targeted genes and inhibit genetic activation. We tested the hypothesis that polyethylene-particle induced chronic inflammatory bone loss could be suppressed by local delivery of NF-κB decoy ODNs in murine in vivo model. Polyethylene particles were continuously infused into the medullary cavity of the distal femur for 6 weeks to induce chronic inflammation, and micro-computational tomography and immunohistochemical analysis were performed. Particle-induced chronic inflammation resulted in lower BMD values, an increase in osteoclastogenesis and nuclear translocation of p65, a prolonged M1 pro-inflammatory macrophage phenotype, and a decrease of M2 anti-inflammatory macrophage phenotype. Delayed timing of local infusion of NF-κB decoy ODN for the last 3 weeks reversed polyethylene-particle associated chronic inflammatory bone loss and facilitated bone healing. This study demonstrated that polyethylene-particle associated chronic inflammatory osteolysis can be effectively modulated via interference with the NF-κB pathway; this minimally invasive intervention could potentially be an efficacious therapeutic strategy for periprosthetic osteolysis after TJA.

Indexed as

Alkaline PhosphataseAnimalsCell NucleusChronic DiseaseDisease Models, AnimalInflammationMacrophagesMaleMiceMice, Inbred BALB CNF-kappa BOligodeoxyribonucleotidesOsteogenesisOsteolysisPhenotypePolyethyleneAlkaline PhosphataseNF-kappa BOligodeoxyribonucleotidesPolyethyleneTranscription Factor RelAbone healinginflammationmacrophageoligodeoxynucleotideosteolysis

Identifiers

PMID33779115
PMCPMC8373802
OpenAlexW3152459470

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.